Current Pharmaceutical Design
Title:Meet Our Editorial Board Member
Volume: 21 Issue: 19
Author(s): Claudio Soto
Affiliation:
Export Options
About this article
Cite this article as:
Soto Claudio, Meet Our Editorial Board Member, Current Pharmaceutical Design 2015; 21 (19) . https://dx.doi.org/10.2174/138161282119150513124639
DOI https://dx.doi.org/10.2174/138161282119150513124639 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
23
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neuroimagenomics for the Study of Human Obesity
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Update on Pharmacologic Retinal Vascular Toxicity
Current Pharmaceutical Design The Role of Circadian Rhythms in Fatal Arrhythmias and the Potential Impact of Intervention for Sleep-Disordered Breathing
Current Pharmaceutical Design A MicroRNA-BDNF Negative Feedback Signaling Loop in Brain: Implications for Alzheimer’s Disease
MicroRNA Therapeutic Targeting of CD6 in Autoimmune Diseases: A Review of Cuban Clinical Studies with the Antibodies IOR-T1 and Itolizumab
Current Drug Targets Gender Difference of Hepatic and Intestinal CYP3A4 in CYP3AHumanized Mice Generated by a Human Chromosome-engineering Technique
Drug Metabolism Letters Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Other Anti- Inflammatory Agents in the Treatment of Neurodegenerative Disease
Current Alzheimer Research Different Morphology of Neuritic Plaques in the Archicortex of Alzheimer’s Disease with Comorbid Synucleinopathy: A Pilot Study
Current Alzheimer Research Memantine Treatment in Patients with Mild to Moderate Alzheimers Disease Already Receiving a Cholinesterase Inhibitor: A Randomized, Double-Blind, Placebo-Controlled Trial
Current Alzheimer Research Advances of Phenoxazines: Synthesis, Reactivity and Their Medicinal Applications
Current Medicinal Chemistry Stem Cell Therapies
Recent Patents on Regenerative Medicine The Genetic Components of Alcohol and Nicotine Co-Addiction: From Genes to Behavior
Current Drug Abuse Reviews NGF and BDNF Alterations by Prenatal Alcohol Exposure
Current Neuropharmacology Editorial (Thematic Issue: Inhibition of Botulinum Neurotoxin BoNT/A)
Current Topics in Medicinal Chemistry Current and Future Applications of Probiotics
Current Nutrition & Food Science Crosstalk between Gut Microbiota and the Central Nervous System in Multiple Sclerosis: Strengths, Weaknesses, Opportunities and Threats Analysis of the Use of An Experimental Model
CNS & Neurological Disorders - Drug Targets Systemic Autoimmune Manifestations: When Should Underlying Thyroid Autoimmunity be Considered?
Current Rheumatology Reviews Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Adhesion Molecules as Potential Novel Biomarkers for Opioid Dependence
Current Pharmaceutical Design Effects of Iron Polymaltose Complex, Ferrous Fumarate and Ferrous Sulfate Treatments in Anemic Pregnant Rats, Their Fetuses and Placentas
Inflammation & Allergy - Drug Targets (Discontinued)